Atlas Trials

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Clinical trial NCT01957644 · TERMINATED

Trial details

NCT number
NCT01957644
Sponsor
Boehringer Ingelheim
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Start date
2013-11-06
Primary completion
2016-12-16
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.